Combinatorial network of transcriptional regulation and microRNA regulation in human cancer

Hui Yu1, Kang Tu, Yi-Jie Wang

  • 1Key Lab of Systems Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China.

BMC Systems Biology
|June 14, 2012
PubMed
Abstract

Insights

This study integrates forward and reverse engineering to build a comprehensive gene regulatory network in human cancer. This network combines transcriptional and microRNA regulation for a more accurate understanding of cancer gene control.

Area of Science:

  • Systems Biology
  • Genomics
  • Bioinformatics

Background:

  • Transcriptional and microRNA (miRNA) control are essential cellular regulatory mechanisms.
  • Current methods for constructing regulatory networks often rely on limited forward engineering strategies.
  • Integrating reverse engineering with forward engineering can yield more accurate and specific combinatorial regulatory networks.

Purpose of the Study:

  • To develop a genome-scale combinatorial gene regulatory network for human cancer.
  • To integrate both transcriptional and miRNA regulations within this network.
  • To enable systematic study of gene regulation in cancer.

Main Methods:

  • Utilized sequence-matching information and parallel expression datasets of miRNAs and mRNAs.
  • Integrated forward and reverse engineering strategies.
  • Validated regulatory relationships using random permutation and experimental databases.

Main Results:

  • Constructed a hypothetical combinatorial gene regulatory network in human cancer.
  • Explored the global and local architecture of the network.
  • Identified key tumor-regulating miRNAs and transcription factors (TFs) based on topological analysis.

Conclusions:

  • Successfully integrated forward and reverse engineering to create a genome-scale combinatorial gene regulatory network for human cancer.
  • The developed network includes both transcriptional and miRNA regulations, facilitating systematic cancer gene regulation studies.
  • Established a pipeline extendable to reveal context-specific combinatorial regulatory landscapes.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...